Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 May;99(5):821–829. doi: 10.3324/haematol.2013.096420

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© Ferrata Storti Foundation

PMC Copyright notice

Figure 2. — Survival curves using Kaplan-Meier analysis in 103 patients with inv(3)/t(3;3) MDS and AML. (A) OS in inv(3)/t(3;3) MDS vs. inv(3)/t(3;3) AML. (B) OS in chemotherapy with allogeneic stem cell transplant vs. chemotherapy alone vs. supportive therapy (P=0.029 log rank). (C) OS in complex vs. non-complex karyotype (P<0.001 logrank). (D) OS in monosomal vs. non-monosomal karyotype (P=0.002 log rank) inv(3)/t(3;3): inv(3)(q21q26.2)/t(3;3)(q21;q26.2). MDS: myelodysplastic syndrome; AML: acute myeloid leukemia; OS: overall survival; CTX-T: chemotherapy with stem cell transplant; CTX: chemotherapy; CK: complex karyotype; MK: monosomal karyotype.